Exact Mass: 545.2447104
Exact Mass Matches: 545.2447104
Found 500 metabolites which its exact mass value is equals to given mass value 545.2447104
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Dihydrozeatin-9-N-glucoside-O-glucoside
Dihydrozeatin-9-N-glucoside-O-glucoside is involved in the cytokinin O-glucoside biosynthesis which occurs in the nuclei and cytosol of plant cells. Cytokinins play an important role in the regulation of numerous physiological reactions in plants. Dihydrozeatin undergoes an N-glucosylation to form dihydrozeatin-9-N-glucoside. This product is then conjugated into an O-glucoside. This latter reaction is reversible and beta-glucosidases can remove the addition at the O-position, which yields back dihydrozeatin-9-N-glucoside. The molecule can then regain its physiological activity. The process is perceived as a way to store the molecule by inactivating it temporarily. A human metabolite taken as a putative food compound of mammalian origin [HMDB]. Dihydrozeatin-9-N-glucoside-O-glucoside is found in many foods, some of which are sunburst squash (pattypan squash), canada blueberry, chayote, and lemon verbena.
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine is an acyl glycine and a sulfated bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). As a bile acid sulfate, N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine is typically found in urine. These conjugates are formed as a part of detoxification of endogenous and exogenous components in the body (PMID:3584362). [HMDB] N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine is an acyl glycine and a sulfated bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895). As a bile acid sulfate, N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine is typically found in urine. These conjugates are formed as a part of detoxification of endogenous and exogenous components in the body (PMID:3584362).
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895) [HMDB] N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895).
Glycocholic acid 3-sulfate
C26H43NO9S (545.2658388000001)
7-(1,5-dimethyl-3-(phenoxymethyl)-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylic acid
homoharringtonine
Omacetaxine_mepesuccinate
Omacetaxine mepesuccinate is a cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia. It has a role as an antineoplastic agent, a protein synthesis inhibitor, an apoptosis inducer and an anticoronaviral agent. It is an alkaloid ester, a tertiary alcohol, an organic heteropentacyclic compound and an enol ether. It is functionally related to a cephalotaxine. Omacetaxine mepesuccinate (formerly known as HHT or Homoharringtonine), is a cephalotaxine ester and protein synthesis inhibitor with established clinical activity as a single agent in hematological malignancies. Omacetaxine mepesuccinate is synthesized from cephalotaxine, which is an extract from the leaves of the plant, Cephalotaxus species. In October 2005, omacetaxine mepesuccinate received Orphan Drug designation from the EMEA for the treatment of chronic myeloid leukemia (CML). Then in March 2006, it received Orphan Drug status from the FDA for the treatment of CML. In November 2006, omacetaxine mepesuccinate, for the treatment of CML, was granted Fast Track designation by the FDA. Most recently, in October 2012, omacetaxine mepesuccinate was marketed under the brand name Synribo and FDA approved for patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML. Omacetaxine mepesuccinate is a natural product found in Cephalotaxus harringtonia and Cephalotaxus fortunei with data available. Omacetaxine Mepesuccinate is a semisynthetic formulation of the cytotoxic plant alkaloid homoharringtonine isolated from the evergreen tree Cephalotaxus with potential antineoplastic activity. Omacetaxine binds to the 80S ribosome in eukaryotic cells and inhibits protein synthesis by interfering with chain elongation. This agent also induces differentiation and apoptosis in some cancer cell types. Semisynthetic derivative of harringtonine that acts as a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC. See also: Omacetaxine (has active moiety). A cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia. D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D006248 - Harringtonines C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product C1907 - Drug, Natural Product Homoharringtonine (Omacetaxine mepesuccinate;HHT) is a cytotoxic alkaloid with antitumor properties which acts by inhibiting translation elongation. Homoharringtonine (Omacetaxine mepesuccinate;HHT) is a cytotoxic alkaloid with antitumor properties which acts by inhibiting translation elongation.
homoharringtonine
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D006248 - Harringtonines C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2287 C1907 - Drug, Natural Product relative retention time with respect to 9-anthracene Carboxylic Acid is 0.650 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.645 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.646 Homoharringtonine (Omacetaxine mepesuccinate;HHT) is a cytotoxic alkaloid with antitumor properties which acts by inhibiting translation elongation. Homoharringtonine (Omacetaxine mepesuccinate;HHT) is a cytotoxic alkaloid with antitumor properties which acts by inhibiting translation elongation.
His Phe Gln Asp
Phe Ser His Arg
Arg Asn Gln Glu
Gln Phe His Asp
Arg Gln Asn Glu
N-[(3a,5b,7a,12a)-7,12-Dihydroxy-24-oxo-3-(sulfooxy)cholan-24-yl]glycine
C26H43NO9S (545.2658388000001)
BA-148-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-148-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-148-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-148-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-148-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
Ala His Arg Tyr
Ala His Tyr Arg
Ala Asn Arg Trp
Ala Asn Trp Arg
Ala Arg His Tyr
Ala Arg Asn Trp
Ala Arg Trp Asn
Ala Arg Tyr His
Ala Trp Asn Arg
Ala Trp Arg Asn
Ala Tyr His Arg
Ala Tyr Arg His
Cys His Met Arg
C20H35N9O5S2 (545.2202460000001)
Cys His Arg Met
C20H35N9O5S2 (545.2202460000001)
Cys Met His Arg
C20H35N9O5S2 (545.2202460000001)
Cys Met Arg His
C20H35N9O5S2 (545.2202460000001)
Cys Arg His Met
C20H35N9O5S2 (545.2202460000001)
Cys Arg Met His
C20H35N9O5S2 (545.2202460000001)
Asp Phe His Lys
C25H35N7O7 (545.2597840000001)
Asp Phe His Gln
Asp Phe Lys His
C25H35N7O7 (545.2597840000001)
Asp Phe Gln His
Asp His Phe Lys
C25H35N7O7 (545.2597840000001)
Asp His Phe Gln
Asp His Lys Phe
C25H35N7O7 (545.2597840000001)
Asp His Gln Phe
Asp Lys Phe His
C25H35N7O7 (545.2597840000001)
Asp Lys His Phe
C25H35N7O7 (545.2597840000001)
Asp Gln Phe His
Asp Gln His Phe
Asp Gln Gln Arg
Asp Gln Arg Gln
Asp Arg Gln Gln
Glu Phe His Asn
Glu Phe Asn His
Glu His Phe Asn
Glu His Asn Phe
Glu Asn Phe His
Glu Asn His Phe
Glu Asn Gln Arg
Glu Asn Arg Gln
Glu Gln Asn Arg
Glu Gln Arg Asn
Glu Arg Asn Gln
Glu Arg Gln Asn
Phe Asp His Lys
C25H35N7O7 (545.2597840000001)
Phe Asp His Gln
Phe Asp Lys His
C25H35N7O7 (545.2597840000001)
Phe Asp Gln His
Phe Glu His Asn
Phe Glu Asn His
Phe Gly His Trp
Phe Gly Trp His
Phe His Asp Lys
C25H35N7O7 (545.2597840000001)
Phe His Asp Gln
Phe His Glu Asn
Phe His Gly Trp
Phe His Lys Asp
C25H35N7O7 (545.2597840000001)
Phe His Asn Glu
Phe His Gln Asp
Phe His Arg Ser
Phe His Ser Arg
Phe His Trp Gly
Phe Lys Asp His
C25H35N7O7 (545.2597840000001)
Phe Lys His Asp
C25H35N7O7 (545.2597840000001)
Phe Asn Glu His
Phe Asn His Glu
Phe Pro Pro Trp
Phe Pro Trp Pro
Phe Gln Asp His
Phe Gln His Asp
Phe Arg His Ser
Phe Arg Ser His
Phe Ser Arg His
Phe Trp Gly His
Phe Trp His Gly
Phe Trp Pro Pro
Gly Phe His Trp
Gly Phe Trp His
Gly His Phe Trp
Gly His Trp Phe
Gly Gln Arg Trp
Gly Gln Trp Arg
Gly Arg Gln Trp
Gly Arg Trp Gln
Gly Trp Phe His
Gly Trp His Phe
Gly Trp Gln Arg
Gly Trp Arg Gln
His Ala Arg Tyr
His Ala Tyr Arg
His Cys Met Arg
C20H35N9O5S2 (545.2202460000001)
His Cys Arg Met
C20H35N9O5S2 (545.2202460000001)
His Asp Phe Lys
C25H35N7O7 (545.2597840000001)
His Asp Phe Gln
His Asp Lys Phe
C25H35N7O7 (545.2597840000001)
His Asp Gln Phe
His Glu Phe Asn
His Glu Asn Phe
His Phe Asp Lys
C25H35N7O7 (545.2597840000001)
His Phe Asp Gln
His Phe Glu Asn
His Phe Gly Trp
His Phe Lys Asp
C25H35N7O7 (545.2597840000001)
His Phe Asn Glu
His Phe Arg Ser
His Phe Ser Arg
His Phe Trp Gly
His Gly Phe Trp
His Gly Trp Phe
His Ile Asn Tyr
C25H35N7O7 (545.2597840000001)
His Ile Tyr Asn
C25H35N7O7 (545.2597840000001)
His Lys Asp Phe
C25H35N7O7 (545.2597840000001)
His Lys Phe Asp
C25H35N7O7 (545.2597840000001)
His Lys Met Met
His Leu Asn Tyr
C25H35N7O7 (545.2597840000001)
His Leu Tyr Asn
C25H35N7O7 (545.2597840000001)
His Met Cys Arg
C20H35N9O5S2 (545.2202460000001)
His Met Lys Met
His Met Met Lys
His Met Arg Cys
C20H35N9O5S2 (545.2202460000001)
His Asn Glu Phe
His Asn Phe Glu
His Asn Ile Tyr
C25H35N7O7 (545.2597840000001)
His Asn Leu Tyr
C25H35N7O7 (545.2597840000001)
His Asn Tyr Ile
C25H35N7O7 (545.2597840000001)
His Asn Tyr Leu
C25H35N7O7 (545.2597840000001)
His Gln Asp Phe
His Gln Phe Asp
His Gln Val Tyr
C25H35N7O7 (545.2597840000001)
His Gln Tyr Val
C25H35N7O7 (545.2597840000001)
His Arg Ala Tyr
His Arg Cys Met
C20H35N9O5S2 (545.2202460000001)
His Arg Phe Ser
His Arg Met Cys
C20H35N9O5S2 (545.2202460000001)
His Arg Ser Phe
His Arg Tyr Ala
His Ser Phe Arg
His Ser Arg Phe
His Val Gln Tyr
C25H35N7O7 (545.2597840000001)
His Val Tyr Gln
C25H35N7O7 (545.2597840000001)
His Trp Phe Gly
His Trp Gly Phe
His Tyr Ala Arg
His Tyr Ile Asn
C25H35N7O7 (545.2597840000001)
His Tyr Leu Asn
C25H35N7O7 (545.2597840000001)
His Tyr Asn Ile
C25H35N7O7 (545.2597840000001)
His Tyr Asn Leu
C25H35N7O7 (545.2597840000001)
His Tyr Gln Val
C25H35N7O7 (545.2597840000001)
His Tyr Arg Ala
His Tyr Val Gln
C25H35N7O7 (545.2597840000001)
Ile His Asn Tyr
C25H35N7O7 (545.2597840000001)
Ile His Tyr Asn
C25H35N7O7 (545.2597840000001)
Ile Met Pro Trp
Ile Met Trp Pro
Ile Asn His Tyr
C25H35N7O7 (545.2597840000001)
Ile Asn Asn Trp
C25H35N7O7 (545.2597840000001)
Ile Asn Trp Asn
C25H35N7O7 (545.2597840000001)
Ile Asn Tyr His
C25H35N7O7 (545.2597840000001)
Ile Pro Met Trp
Ile Pro Trp Met
Ile Trp Met Pro
Ile Trp Asn Asn
C25H35N7O7 (545.2597840000001)
Ile Trp Pro Met
Ile Tyr His Asn
C25H35N7O7 (545.2597840000001)
Ile Tyr Asn His
C25H35N7O7 (545.2597840000001)
Lys Asp Phe His
C25H35N7O7 (545.2597840000001)
Lys Asp His Phe
C25H35N7O7 (545.2597840000001)
Lys Phe Asp His
C25H35N7O7 (545.2597840000001)
Lys Phe His Asp
C25H35N7O7 (545.2597840000001)
Lys His Asp Phe
C25H35N7O7 (545.2597840000001)
Lys His Phe Asp
C25H35N7O7 (545.2597840000001)
Lys His Met Met
Lys Met His Met
Lys Met Met His
Leu His Asn Tyr
C25H35N7O7 (545.2597840000001)
Leu His Tyr Asn
C25H35N7O7 (545.2597840000001)
Leu Met Pro Trp
Leu Met Trp Pro
Leu Asn His Tyr
C25H35N7O7 (545.2597840000001)
Leu Asn Asn Trp
C25H35N7O7 (545.2597840000001)
Leu Asn Trp Asn
C25H35N7O7 (545.2597840000001)
Leu Asn Tyr His
C25H35N7O7 (545.2597840000001)
Leu Pro Met Trp
Leu Pro Trp Met
Leu Trp Met Pro
Leu Trp Asn Asn
C25H35N7O7 (545.2597840000001)
Leu Trp Pro Met
Leu Tyr His Asn
C25H35N7O7 (545.2597840000001)
Leu Tyr Asn His
C25H35N7O7 (545.2597840000001)
Met Cys His Arg
C20H35N9O5S2 (545.2202460000001)
Met Cys Arg His
C20H35N9O5S2 (545.2202460000001)
Met His Cys Arg
C20H35N9O5S2 (545.2202460000001)
Met His Lys Met
Met His Met Lys
Met His Arg Cys
C20H35N9O5S2 (545.2202460000001)
Met Ile Pro Trp
Met Ile Trp Pro
Met Lys His Met
Met Lys Met His
Met Leu Pro Trp
Met Leu Trp Pro
Met Met His Lys
Met Met Lys His
Met Pro Ile Trp
Met Pro Leu Trp
Met Pro Trp Ile
Met Pro Trp Leu
Met Arg Cys His
C20H35N9O5S2 (545.2202460000001)
Met Arg His Cys
C20H35N9O5S2 (545.2202460000001)
Met Trp Ile Pro
Met Trp Leu Pro
Met Trp Pro Ile
Met Trp Pro Leu
Asn Ala Arg Trp
Asn Ala Trp Arg
Asn Glu Phe His
Asn Glu His Phe
Asn Glu Gln Arg
Asn Glu Arg Gln
Asn Phe Glu His
Asn Phe His Glu
Asn His Glu Phe
Asn His Phe Glu
Asn His Ile Tyr
C25H35N7O7 (545.2597840000001)
Asn His Leu Tyr
C25H35N7O7 (545.2597840000001)
Asn His Tyr Ile
C25H35N7O7 (545.2597840000001)
Asn His Tyr Leu
C25H35N7O7 (545.2597840000001)
Asn Ile His Tyr
C25H35N7O7 (545.2597840000001)
Asn Ile Asn Trp
C25H35N7O7 (545.2597840000001)
Asn Ile Trp Asn
C25H35N7O7 (545.2597840000001)
Asn Ile Tyr His
C25H35N7O7 (545.2597840000001)
Asn Leu His Tyr
C25H35N7O7 (545.2597840000001)
Asn Leu Asn Trp
C25H35N7O7 (545.2597840000001)
Asn Leu Trp Asn
C25H35N7O7 (545.2597840000001)
Asn Leu Tyr His
C25H35N7O7 (545.2597840000001)
Asn Asn Ile Trp
C25H35N7O7 (545.2597840000001)
Asn Asn Leu Trp
C25H35N7O7 (545.2597840000001)
Asn Asn Trp Ile
C25H35N7O7 (545.2597840000001)
Asn Asn Trp Leu
C25H35N7O7 (545.2597840000001)
Asn Gln Glu Arg
Asn Gln Arg Glu
Asn Gln Val Trp
C25H35N7O7 (545.2597840000001)
Asn Gln Trp Val
C25H35N7O7 (545.2597840000001)
Asn Arg Ala Trp
Asn Arg Glu Gln
Asn Arg Gln Glu
Asn Arg Trp Ala
Asn Val Gln Trp
C25H35N7O7 (545.2597840000001)
Asn Val Trp Gln
C25H35N7O7 (545.2597840000001)
Asn Trp Ala Arg
Asn Trp Ile Asn
C25H35N7O7 (545.2597840000001)
Asn Trp Leu Asn
C25H35N7O7 (545.2597840000001)
Asn Trp Asn Ile
C25H35N7O7 (545.2597840000001)
Asn Trp Asn Leu
C25H35N7O7 (545.2597840000001)
Asn Trp Gln Val
C25H35N7O7 (545.2597840000001)
Asn Trp Arg Ala
Asn Trp Val Gln
C25H35N7O7 (545.2597840000001)
Asn Tyr His Ile
C25H35N7O7 (545.2597840000001)
Asn Tyr His Leu
C25H35N7O7 (545.2597840000001)
Asn Tyr Ile His
C25H35N7O7 (545.2597840000001)
Asn Tyr Leu His
C25H35N7O7 (545.2597840000001)
Pro Phe Pro Trp
Pro Phe Trp Pro
Pro Ile Met Trp
Pro Ile Trp Met
Pro Leu Met Trp
Pro Leu Trp Met
Pro Met Ile Trp
Pro Met Leu Trp
Pro Met Trp Ile
Pro Met Trp Leu
Pro Pro Phe Trp
Pro Pro Trp Phe
Pro Trp Phe Pro
Pro Trp Ile Met
Pro Trp Leu Met
Pro Trp Met Ile
Pro Trp Met Leu
Pro Trp Pro Phe
Gln Asp Phe His
Gln Asp His Phe
Gln Asp Gln Arg
Gln Asp Arg Gln
Gln Glu Asn Arg
Gln Glu Arg Asn
Gln Phe Asp His
Gln Gly Arg Trp
Gln Gly Trp Arg
Gln His Asp Phe
Gln His Phe Asp
Gln His Val Tyr
C25H35N7O7 (545.2597840000001)
Gln His Tyr Val
C25H35N7O7 (545.2597840000001)
Gln Asn Glu Arg
Gln Asn Arg Glu
Gln Asn Val Trp
C25H35N7O7 (545.2597840000001)
Gln Asn Trp Val
C25H35N7O7 (545.2597840000001)
Gln Gln Asp Arg
Gln Gln Arg Asp
Gln Arg Asp Gln
Gln Arg Glu Asn
Gln Arg Gly Trp
Gln Arg Asn Glu
Gln Arg Gln Asp
Gln Arg Trp Gly
Gln Val His Tyr
C25H35N7O7 (545.2597840000001)
Gln Val Asn Trp
C25H35N7O7 (545.2597840000001)
Gln Val Trp Asn
C25H35N7O7 (545.2597840000001)
Gln Val Tyr His
C25H35N7O7 (545.2597840000001)
Gln Trp Gly Arg
Gln Trp Asn Val
C25H35N7O7 (545.2597840000001)
Gln Trp Arg Gly
Gln Trp Val Asn
C25H35N7O7 (545.2597840000001)
Gln Tyr His Val
C25H35N7O7 (545.2597840000001)
Gln Tyr Val His
C25H35N7O7 (545.2597840000001)
Arg Ala His Tyr
Arg Ala Asn Trp
Arg Ala Trp Asn
Arg Ala Tyr His
Arg Cys His Met
C20H35N9O5S2 (545.2202460000001)
Arg Cys Met His
C20H35N9O5S2 (545.2202460000001)
Arg Asp Gln Gln
Arg Glu Asn Gln
Arg Glu Gln Asn
Arg Phe His Ser
Arg Phe Ser His
Arg Gly Gln Trp
Arg Gly Trp Gln
Arg His Ala Tyr
Arg His Cys Met
C20H35N9O5S2 (545.2202460000001)
Arg His Phe Ser
Arg His Met Cys
C20H35N9O5S2 (545.2202460000001)
Arg His Ser Phe
Arg His Tyr Ala
Arg Met Cys His
C20H35N9O5S2 (545.2202460000001)
Arg Met His Cys
C20H35N9O5S2 (545.2202460000001)
Arg Asn Ala Trp
Arg Asn Glu Gln
Arg Asn Trp Ala
Arg Gln Asp Gln
Arg Gln Glu Asn
Arg Gln Gly Trp
Arg Gln Gln Asp
Arg Gln Trp Gly
Arg Ser Phe His
Val His Gln Tyr
C25H35N7O7 (545.2597840000001)
Val His Tyr Gln
C25H35N7O7 (545.2597840000001)
Val Asn Gln Trp
C25H35N7O7 (545.2597840000001)
Val Asn Trp Gln
C25H35N7O7 (545.2597840000001)
Val Gln His Tyr
C25H35N7O7 (545.2597840000001)
Val Gln Asn Trp
C25H35N7O7 (545.2597840000001)
Val Gln Trp Asn
C25H35N7O7 (545.2597840000001)
Val Gln Tyr His
C25H35N7O7 (545.2597840000001)
Val Trp Asn Gln
C25H35N7O7 (545.2597840000001)
Val Trp Gln Asn
C25H35N7O7 (545.2597840000001)
Val Tyr His Gln
C25H35N7O7 (545.2597840000001)
Val Tyr Gln His
C25H35N7O7 (545.2597840000001)
Trp Phe Gly His
Trp Phe His Gly
Trp Phe Pro Pro
Trp Gly Phe His
Trp Gly His Phe
Trp His Phe Gly
Trp His Gly Phe
Trp Ile Met Pro
Trp Ile Asn Asn
C25H35N7O7 (545.2597840000001)
Trp Ile Pro Met
Trp Leu Met Pro
Trp Leu Asn Asn
C25H35N7O7 (545.2597840000001)
Trp Leu Pro Met
Trp Met Ile Pro
Trp Met Leu Pro
Trp Met Pro Ile
Trp Met Pro Leu
Trp Asn Ile Asn
C25H35N7O7 (545.2597840000001)
Trp Asn Leu Asn
C25H35N7O7 (545.2597840000001)
Trp Asn Asn Ile
C25H35N7O7 (545.2597840000001)
Trp Asn Asn Leu
C25H35N7O7 (545.2597840000001)
Trp Asn Gln Val
C25H35N7O7 (545.2597840000001)
Trp Asn Val Gln
C25H35N7O7 (545.2597840000001)
Trp Pro Phe Pro
Trp Pro Ile Met
Trp Pro Leu Met
Trp Pro Met Ile
Trp Pro Met Leu
Trp Pro Pro Phe
Trp Gln Asn Val
C25H35N7O7 (545.2597840000001)
Trp Gln Val Asn
C25H35N7O7 (545.2597840000001)
Trp Val Asn Gln
C25H35N7O7 (545.2597840000001)
Trp Val Gln Asn
C25H35N7O7 (545.2597840000001)
Tyr His Ile Asn
C25H35N7O7 (545.2597840000001)
Tyr His Leu Asn
C25H35N7O7 (545.2597840000001)
Tyr His Asn Ile
C25H35N7O7 (545.2597840000001)
Tyr His Asn Leu
C25H35N7O7 (545.2597840000001)
Tyr His Gln Val
C25H35N7O7 (545.2597840000001)
Tyr His Val Gln
C25H35N7O7 (545.2597840000001)
Tyr Ile His Asn
C25H35N7O7 (545.2597840000001)
Tyr Ile Asn His
C25H35N7O7 (545.2597840000001)
Tyr Leu His Asn
C25H35N7O7 (545.2597840000001)
Tyr Leu Asn His
C25H35N7O7 (545.2597840000001)
Tyr Asn His Ile
C25H35N7O7 (545.2597840000001)
Tyr Asn His Leu
C25H35N7O7 (545.2597840000001)
Tyr Asn Ile His
C25H35N7O7 (545.2597840000001)
Tyr Asn Leu His
C25H35N7O7 (545.2597840000001)
Tyr Gln His Val
C25H35N7O7 (545.2597840000001)
Tyr Gln Val His
C25H35N7O7 (545.2597840000001)
Tyr Arg Ala His
Tyr Arg His Ala
Tyr Val His Gln
C25H35N7O7 (545.2597840000001)
Tyr Val Gln His
C25H35N7O7 (545.2597840000001)
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfoxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfoxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
Dihydrozeatin-9-N-glucoside-O-glucoside
An N-glycosyldihydrozeatin consisting of dihydrozeatin carrying two alpha-D-glucosyl on the oxygen and the nitrogen at position 9 in the purine ring.
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine
C26H43NO9S (545.2658388000001)
Landiolol Hydrochloride
C25H40ClN3O8 (545.2503790000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist Landiolol hydrochloride (ONO1101 hydrochloride) is a highly beta1 selective ultra-short acting beta-blocker (β1/β2 selectivity?=?255:1, a half-life of 4?min), acts as an adrenoceptor antagonist[1].
n-(2-nitrophenylsulfenyl)-s-benzyl-l-cysteine dicyclohexylammonium salt
R(+)-N,N-BIS(2-DIPHENYLPHOSPHINOETHYL)-1-PHENYLETHYLAMINE
3alpha-Sulfooxy-7alpha,12alpha-dihydroxy-5beta-cholan-24-oyl-glycine
C26H43NO9S (545.2658388000001)
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[6-[[(3S)-3-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]amino]purin-9-yl]oxane-3,4,5-triol
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[6-[[(3S)-3-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]amino]purin-9-yl]oxane-3,4,5-triol
N-benzyl-2-phenylethanaminium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
3-(1,3-benzodioxol-5-yl)-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
N-[[(2R,3R)-8-[4-[dimethylamino(oxo)methyl]phenyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(2S,3S)-8-[4-[dimethylamino(oxo)methyl]phenyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(2S,3R)-8-[4-[dimethylamino(oxo)methyl]phenyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(2R,3S)-8-[4-[dimethylamino(oxo)methyl]phenyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(2S,3R)-8-[4-[dimethylamino(oxo)methyl]phenyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(2S,3S)-8-[4-[dimethylamino(oxo)methyl]phenyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(2R,3R)-8-[4-[dimethylamino(oxo)methyl]phenyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(2R,3S)-8-[4-[dimethylamino(oxo)methyl]phenyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-pyridinecarboxamide
3-(1,3-benzodioxol-5-yl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(1,3-benzodioxol-5-yl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
N-[(2R,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(2-pyrrolidin-1-ylethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-cyanobenzamide
3-(1,3-benzodioxol-5-yl)-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(1,3-benzodioxol-5-yl)-1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(1,3-benzodioxol-5-yl)-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
(1R)-N-(3,5-dimethyl-4-isoxazolyl)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide
C26H35N5O6S (545.2307930000001)
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methoxybenzenesulfonamide
3-(1,3-benzodioxol-5-yl)-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
(1S)-N-(3,5-dimethyl-4-isoxazolyl)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide
C26H35N5O6S (545.2307930000001)
(2R,3S,4S,5R)-2-(Hydroxymethyl)-6-{6-[(3-methyl-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)amino]-9H-purin-9-yl}oxane-3,4,5-triol
2-[[(4R)-4-[(3R,5S,7R,10S,12S,13R,17R)-3,7-dihydroxy-10,13-dimethyl-12-sulooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid
C26H43NO9S (545.2658388000001)